Ketotifen increases cyclic adenosine 3',5'-monophosphate in intact human lymphocyte and potentiates other adenylate cyclase activating agents

scientific article published on 01 March 1987

Ketotifen increases cyclic adenosine 3',5'-monophosphate in intact human lymphocyte and potentiates other adenylate cyclase activating agents is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0024-3205(87)90582-0
P698PubMed publication ID3031398

P2093author name stringK K Hui
J L Yu
P433issue13
P407language of work or nameEnglishQ1860
P304page(s)1259-1265
P577publication date1987-03-01
P1433published inLife SciencesQ5256275
P1476titleKetotifen increases cyclic adenosine 3',5'-monophosphate in intact human lymphocyte and potentiates other adenylate cyclase activating agents
P478volume40

Reverse relations

cites work (P2860)
Q69919066Ketotifen prevents terbutaline-induced down-regulation of beta-adrenoceptors in guinea pig lung
Q37977366Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders
Q42557784Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions
Q34550614The mast cell stabilizer ketotifen fumarate lessens contracture severity and myofibroblast hyperplasia: a study of a rabbit model of posttraumatic joint contractures